Epidemiology and pathophysiology of heart failure.
Redfield
M M
MM
Division of Cardiovascular Diseases, Departments of Medicine, Molecular Pharmacology and Experimental Therapeutics, and Physiology, Mayo Clinic and Foundation, 200 First Street SW, Guggenheim-7, Rochester, MN 55905, USA. Redfield.margaret@mayo.edu
D000450:Aldosterone / Q000494:pharmacology; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D018450:Disease Progression; D006333:Heart Failure / Q000453:epidemiology* / Q000503:physiopathology*; D006801:Humans; D015994:Incidence; D011674:Pulse; D017257:Ramipril / Q000627:therapeutic use; D013148:Spironolactone / Q000494:pharmacology; D016019:Survival Analysis; D016277:Ventricular Function, Left / Q000187:drug effects
D000806:Angiotensin-Converting Enzyme Inhibitors; D013148:Spironolactone; D000450:Aldosterone; D017257:Ramipril